Home › Psychomotor Agitation
Psychomotor Agitation clinical trials recruiting in the U.S.
6 studies for Psychomotor Agitation are recruiting participants at sites across the United States.
Cities with the most studies
By state
- Arizona3 studies
- California3 studies
- Florida4 studies
- Georgia3 studies
- New Jersey3 studies
- New York4 studies
- North Carolina3 studies
- Ohio3 studies
- Texas3 studies
Recently updated studies
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Nov 12, 2026 · NCT06937229A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Nov 3, 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Oct 6, 2026 · NCT06808984Neurosteer Bedside Monitoring System
Recruiting
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06718764Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated May 28, 2026 · NCT06781333Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
RecruitingPhase 2
Ages 50 to 90 · All sexes · Updated Feb 16, 2023 · NCT04436081From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.